📰 Gene Mack News
Gene Mack News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gene Mack. Real-time updates on events, politics, business and more.
April 8, 2024
BETHESDA, Md., April 08, 2024 -- Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule...
April 8, 2024
BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
January 23, 2023
The new episode of the WTF Happened to This Horror Movie? video series looks back at George A. Romero's 2005 film Land of the Dead
September 7, 2022
Buster Logan is a figment in the imagination of Rio Rancho author Don Shearer, whose new book “The Ballpark Buster” has just been published.
April 12, 2022
Medford fire chief assigns two details to all shows at the Chevalier Theatre to ensure the public is protected from fire hazard
November 3, 2021
DGAP-News: Imcyse SA / Key word(s): Personnel Imcyse Appoints Gene Mack, MBA as Chief Financial Officer 03.11.2021 / 13:00 The issuer is solely responsible for the content of this announcement. Imcyse Appoints Gene Mack, MBA as Chief Financial Officer Liège, Belgium, November 3, 2021 - Imcyse, a...
October 15, 2021
Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., will retire at the end of the year, following the lead of CEO Alex Gorsky, who also departs soon. Emile Nuwaysir led Bayer's $1 billion bet on Parkinson's disease, and now he heads up gene therapy biotech Ensoma. Genentech's early cancer research leader Shiva Malek jumps to Novartis' NIBR oncology unit.
October 12, 2021
HOUSTON, Oct. 12, 2021 -- Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells and Treg-derived exosome...